Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: AMERISOURCEBERGEN DRUG CORP
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-01-09 to 2023-01-10
Current total value of award: $1852.69
Description: 4559542643!QUILLIVANT XR ORAL SUSP 180ML 5MG/ML